Open Access Article
O deoxygenation of carbamates and polyurethane catalyzed by organoactinide complexes
Tamer Saiaede†
a,
Ida Ritacco†
b,
Lucia Caporaso*bc and
Moris S. Eisen
*a
aSchulich Faculty of Chemistry, Technion – Israel Institute of Technology, Technion City, 3200008, Israel. E-mail: chmoris@technion.ac.il
bDipartimento di Chimica e Biologia “Adolfo Zambelli”, Università degli Studi di Salerno, Via Giovanni Paolo II, 132 – 84084 Fisciano, Salerno, Italy. E-mail: lcaporaso@unisa.it
cCNR-IOM, Consiglio Nazionale Delle Ricerche – Istituto Officina Dei Materiali, C/o SISSA, Trieste, 34136, Italy
First published on 23rd April 2026
The remarkable ability of actinide complexes to activate carbamates is presented in this study, exemplified by the carbamate hydroboration using various Th and U complexes. The activation mode involves the selective catalytic cleavage of the C–O bond and the deoxygenation of the double C
O bond, utilizing pinacolborane (HBpin) as a hydride source. The broad scope of the organoactinides allows us to perform the activation reaction with diverse structural and functional carbamates, offering a flexible strategy for the synthesis of complex amines and amino alcohols. For example, the synthesis of (−) ephedrine and other bioactive analog molecules was achieved in a one-pot, two-step reaction utilizing commercially available carbamate derivatives, including multigram-scale reactions. Additionally, the capability of actinide catalysts to facilitate late-stage modifications of drugs has been extensively studied, and various pharmaceutical compounds have been examined. Notably, we also present the homogeneous catalytic depolymerization of a polyurethane polymer, recycling it to its valuable diamine [Me–N(H)–R–N(H)–Me] through hydroboration followed by hydrolysis. The use of an organic-f-lanthanide compound is also presented as a comparison to the actinides to show their industrial applicability. To understand the reactivity of the actinide complexes, stoichiometric reactions, together with kinetic experiments, thermodynamic measurements, and deuterium labeling studies, were performed, allowing us to propose a mechanistic pathway. Computational DFT calculations further substantiate the proposed mechanism.
O reduction followed by a C–O bond cleavage), via their hydroboration (Fig. 1A, left side).29,30 In addition, the use of thorium or uranium imidazolin-2-iminato complexes showed the ability to induce the deoxygenation of isocyanates toward N-methylamines through the formation of formamide intermediates via C
N bond reduction, followed by deoxygenation (Fig. 1B).31 To the best of our knowledge, the use of organo-f-complexes to activate carbamates has not been reported. In this regard, the catalytic activity and mode of action of the organo-f-complexes in this area are interesting, particularly for enhanced selectivity and reactivity to either multifunctional or stable carbamates, including polymers and bioactive molecules. To this end, based on the previous ester, carbonate, isocyanate, and amide protocols,28–31 activating carbamates (Fig. 1C), will display recycling a hydride, An–H, from the corresponding oxide, An–O, via a C–O bond cleavage as in esters or carbonates, and the C
O deoxygenation as in amides and isocyanates, which eventually will streamline the catalytic activation of carbamates. It will provide direct access to the synthesis of valuable, multi-functional moieties, such as amino alcohols, N-methylamines, and tertiary alkylamines, using carbamates as a promising feedstock. Moreover, the carbamate moiety and its corresponding deoxygenative bond cleavage products are also widely present in natural products, pharmaceuticals, and polymers.32–37 However, its reduction using reagents such as LiAlH4 often lacks selectivity.38,39 Therefore, a selective mode of activation of multi-functional carbamates, particularly drug molecules, is both required and desirable; this selective modification of drug molecules can be considered a powerful and attractive method for developing and discovering new drug molecules.36,37,40 The research presented here is also motivated by the potential use of carbamates to produce complex amines, amino alcohols, and methylamine products, a framework that exists in a large number of drug molecules (Fig. 1D), and has wide applications in catalysis.36,37,40
O bond and the cleavage of the C–O Sigma bond to afford the corresponding borylated 2-dimethylaminoethanol (1′a) and bis(pinacolboryl)oxide (pinB-O-Bpin) as a coproduct. Interestingly, complex I exhibited high catalytic activity when toluene was used as a solvent at a higher temperature (110 °C), achieving a 72% conversion in 24 hours. Complexes II and III yielded conversions of 70% and 62%, respectively (Table 1, entries 5–7). The use of different hydride sources (Table 1, entries 8–11) demonstrated that HBpin and 9-BBN are effective hydride reagents for the hydroboration and the ring cleavage of the cyclic carbamate.
| Entry | Catalyst [3%] | Solvent | H-source | Temp [°C] | Time [h] | Yieldb [%] |
|---|---|---|---|---|---|---|
| a Reaction conditions: 3-methyl-2-oxazolidinone (1a) (0.2 mmol), hydride source (0.63 mmol), An (mol 3%), solvent (0.65 mL), 110 °C and 24 h.b Yields were determined by 1H NMR spectroscopy of the crude reaction mixture with an internal standard of hexamethylbenzene.c HBCat (catecholborane). | ||||||
| 1 | I | THF | H-Bpin | 66 | 48 | — |
| 2 | I | Benzene | H-Bpin | 80 | 24 | 20 |
| 3 | II | Benzene | H-Bpin | 80 | 24 | 16 |
| 4 | III | Benzene | H-Bpin | 80 | 24 | 14 |
| 5 | I | Toluene | H-Bpin | 110 | 24 | 72 |
| 6 | II | Toluene | H-Bpin | 110 | 24 | 70 |
| 7 | III | Toluene | H-Bpin | 110 | 24 | 62 |
| 8 | II | Toluene | 9-BBN | 110 | 24 | 84 |
| 8 | II | Toluene | BH3*THF | 110 | 24 | 8 |
| 9 | II | Toluene | HBCatc | 110 | 24 | Traces |
| 10 | II | Toluene | PhSiH3 | 110 | 24 | 13 |
| 11 | II | Toluene | Et3SiH | 110 | 24 | 0 |
| 12 | — | Toluene | H-Bpin | 110 | 24 | — |
However, since we monitor the reactions by NMR, 9-BBN affords a complex spectrum as compared to HBpin, with broad multiple peaks in 9-BBN versus a sharp singlet in HBpin. Hence, we studied the substrate scope using HBpin and the three actinide complexes I–III. No reaction occurred in the absence of the actinide complexes (Table 1, entry 12).
Having established a viable protocol for the deoxygenation and hydroboration of carbamates, we explored the substrate scope of the general reaction (Fig. 2A). We started our scope studies with the protected cyclic carbamate 2-oxazolidinones (Fig. 2B). First, the 3-methyl and 3-trimethylsilyl oxazolidinones (1a and 1b) were studied, and the corresponding products were obtained in moderate to excellent NMR yields (50–95%) using complexes I, II, and III in 24 hours. In the case of the trimethylsilyl derivative (1b), the Th(IV) iminato complex III showed a better catalytic activity as compared with its Th(IV) metallacycle precursor II, 95% vs. 48%. Furthermore, a variety of free N–H cyclic carbamates were studied. 2-Oxazolidinones and 1,3-oxazinan-2-one (1c and 1d) were effectively activated and achieved quantitative yields using the three complexes in only 2–4 hours, indicating that neither the ring size nor the free NH amido group inhibits the reactivity of the complexes. Next, we examined a set of different substitutions at the 2-oxazolidinones (1e, 1f, 1g, and 1h), and it was found that our catalysts I–III effectively activated the carbamates towards the corresponding 1,3-aminoalcohols in good to excellent NMR yields, ranging from 72% to 95%, in an overnight reaction. For substrate 1h, the chirality of the substrate remains unaffected. Interestingly, these actinide catalysts were also active with the 2-oxazolidinone containing a primary alcohol derivative (1i), which was converted to the corresponding borylated amino-alcohol, reaching excellent yields up to 84% in 24 h, illustrating that the hydroxyl group does not have a major effect on the catalytic activity of these actinide complexes under the reaction conditions. Hence, a variety of N-phenyl-protected 5-(hydroxymethyl)-3-phenyloxazolidin-2-one carbamates (1j, 1k, 1l, and 1m) were studied, showing a small effect on the reactivity of the three catalysts, with conversions ranging from 70% to 92% in 24 hours. Moreover, the reactivity of different ethylamidecarbamate (1n) or benzyloxycarbonyl Cbz-aliphatic carbamates (1o and 1p) was found to be similar to the reactivity obtained with the 2-oxazolidinone derivatives with good to excellent yields (84%–95%) after 12 h. The reaction scope was next explored with a series of aromatic non-cyclic carbamates (1q–1w), featuring electron-withdrawing groups (e.g., CF3) and electron-donating groups (e.g., Me), as well as different alkyl chains, yielding excellent results in 4–16 hours. Concerning the alkoxide OR chains, it was found that the bulkiness of the OR moiety significantly affects the catalytic reactivity. The carbamate with the O–Me group (1u) reached almost quantitative yield in 4 hours, while the corresponding isopropyl derivatives (1v and 1w) achieved excellent yields only after 16 hours. Moreover, the tert-butyl aliphatic carbamate (1x) showed only trace conversions after 24 h. To highlight the synthetic potential of activating carbamates via their hydroboration, followed by deoxygenation and C–O cleavage to obtain the corresponding N–Me derivatives, we focused on investigating the potential ability to synthesize drug or drug analog molecules (Fig. 2C). In this regard, the use of the commercially available (4S,5R)-(−)-4-methyl-5-phenyl-2-oxazolidinone (1y) produces the corresponding borylated (−) ephedrine drug molecule 1′y using the An(IV) metallacycles [An = Th (I); U (II)] in excellent yields of 80–95%, which also participates furthermore in ligand synthesis, providing the ligand precursor 1′yPCl. Next, we explored the potential application of this protocol by performing gram and 2-gram-scale reactions. Delightfully, no substantial loss of the yield was noticed; the reaction delivered the (−) ephedrine drug molecule (1′y-H) after its isolation in excellent yields of 91% and 90% in 48 h, using a 1% mmol of the An(IV) metallacycle (II), instead of 3% mmol (Fig. 2C). Moreover, for synthetic application, we extend this gram-scale protocol using the commercially available La+3 complex [tris[N,N-bis(trimethylsilyl)amide]lanthanum(III)]. The lanthanide complex also showed excellent activity at 1% mmol, yielding the corresponding isolated (−) ephedrine.
The (–) ephedrine molecule 1′y-H was obtained in 82% yield after 48 h, maintaining the chiral center intact (Fig. 2C). Next, a fluorinated ephedrine drug analog (1′z) was effectively produced in 93%, 95%, and 82% yields using catalysts [I–III], respectively, within 24 hours, using the commercially available fluorinated 4-methyl-5-phenyl-2-oxazolidinone (1z) substrate. In addition, the 4-benzyl-2-oxazolidinone (1aa) was effectively transformed into the methamphetamine drug analog 1′aa, containing a hydroxyl group on the terminal carbon, by catalysts I, II, and III in 2 hours, reaching quantitative yields of 99%, 94%, and 99%, respectively (Fig. 2C). Another intriguing and challenging area is polymer recycling. Carbamate-based polymers are widely used in industry owing to their wide applications, which stem from their exceptional stability.44–46 However, their stability makes them difficult to recycle or even transform. As a result, the depolymerization of polyurethanes to manufacture high-value chemicals, e.g., methylamine-containing compounds, has remained unachievable under the conditions of a homogeneous catalytic protocol.47–49 Therefore, we focused on investigating the potential ability of the actinide complexes to activate polyurethanes (Fig. 2D). Subsequently, the addition of HBpin to a polyurethane (1ab) in the presence of 3% mmol of the uranium catalyst (II) results in its depolymerization and its conversion into the borylated dimethyldiaminodiphenylmethane (1′ab) and the borylated ethylene glycol with good yields (74%) in 24 h, providing a facile catalytic route for a controlled polymer degradation. A simple silica-gel purification of the borylated compound 1′ab, yielded the corresponding hydrolyzed free N–H dimethyldiaminodiphenylmethane (1′ab-H), which was isolated in good yield (61%). It is worth mentioning that this protocol presents, for the first time, the homogeneous transformation of a polyurethane into a methylamine framework. It is well known that organic synthesis remains the rate-limiting factor in drug discovery despite decades of groundbreaking research in academia.33 In this regard, a late-stage modification or functionalization signifies a valuable methodology for rapidly constructing novel analogs of drug molecules and pharmaceutically active agents. Therefore, to highlight the applicability of this protocol, we evaluated the carbamate activation methodology (hydroboration followed by deoxygenation, ring opening for cyclic carbamates, and protonolysis during the purification) with biologically active compounds and natural products (Fig. 3). As shown in Fig. 3, the current strategy provides practical evidence for the late stage deoxygenative hydroboration of various biologically active carbamate compounds, including commercial pharmaceuticals. The modified scope was studied by investigating the drug metaxalone (1ac). Metaxalone effectively underwent hydroboration, ring opening and deoxygenation towards the diborylated 1-(3,5-dimethylphenoxy)-3-(methylamino)propan-2-ol 1′ac, with quantitative conversion (>99%) in 24 h using any of the three catalysts studied (I–III). The hydrolysis of the diborylated 1′ac yields the corresponding 1-(3,5-dimethylphenoxy)-3-(methylamino)propan-2-ol (1ac-H) in 81% isolated yield. The incorporation of the N-trideuteromethyl group into pharmaceuticals has been shown to enhance their metabolic stability.50 Hence, metaxalone transformation was performed using D-Bpin, displaying a similar reactivity to HBpin. The corresponding diborylated, deuterated and modified 1-(3,5-dimethylphenoxy)-3-((methyl-d3)amino)propan-2-ol (1′ac-D) was obtained in quantitative D-incorporation yields after 24 h using complex I.
![]() | ||
| Fig. 3 Carbamate hydroboration for late-stage modification of drug molecules and pharmaceutically active agents. | ||
Next, the drug zolmitriptan (1ad) efficiently participated in this process, affording the biologically interesting products (1′ad) in excellent yields (88%–91%) in 24 h using the three catalysts (I, II, and III). It is worth mentioning that the modified zolmitriptan drug product (1′ad) is highly similar to sumatriptan and relatively similar to rizatriptan and almotriptan, which are other triptan drug molecules. A late-stage modification was also explored using the bioactive drugs metergoline (1ae) and fenoxycarb (1af). Both were hydroborated and deoxygenated with C–O cleavage, yielding the corresponding modified molecules (1′ae and 1′af) smoothly in 24 hours with excellent yields of up to 92% and 99% for metergoline and fenoxycarb, respectively, using the three complexes I–III.
In addition, the drug mephenoxalone (1ag) was successfully modified to the corresponding product (1′ag) in 24 h in excellent yield (∼90%). Interestingly, the mephenoxalone modified product (1′ag) is highly similar to the bioactive molecules, guaifenesin, moprolol, and methocarbamol. Lastly, the drug tedizolid (1ah) was efficiently modified using this protocol, reaching 71–79% of the corresponding products (1′ah) in 24 h using the actinide complexes as presented in Fig. 3.
![]() | (1) |
The activation thermodynamic parameters were calculated from the Eyring and Arrhenius plots over the temperature range of 70–120 °C, displaying an energy of activation (Ea) of 8.46 ± 0.11 kcal mol−1, an enthalpy of activation (ΔH‡) of 7.73 ± 0.11 kcal mol−1, and a large negative entropy of activation (ΔS‡) of −55.9 ± 3.0 eu. The ΔS‡ data are consistent with a simultaneous bond-cleavage and bond-formation event with a very organized four-membered ring at the rate-determining step.
![]() | ||
| Fig. 4 Competitive activation of carbamates and substrates with additional functional groups by the uranium complex II. | ||
The same reactivity was observed when equimolar amounts of the carbamate and benzyl-formamide (0.2 mmol) were activated at the same time, producing only the N-methylbenzylamine and the diborane pinBOBpin, keeping the carbamate intact. This reactivity is attributed to the reactive nature of the different carbonyl groups. Hence, a subsequent competitive experiment was conducted between equimolar amounts of 3-methyl-2-oxazolidinone (1a) and the corresponding unprotected 2-oxazolidinone (1c) (0.2 mmol). As expected, the activation occurred on the 2-oxazolidinone (1c) due to the difference in electronic effects between the two substrates (vide infra). Competition between 2-oxazolidinones (1c) and benzylformamide is more intriguing. The competition hydroboration between equimolar amounts of 2-oxazolidinones (1c) and benzylformamide using 0.6 mmol of HBpin resulted in the hydroboration of the benzylformamide with 67% conversion and the hydroboration of 2-oxazolidinones (1c) with a conversion of 48%. This suggests that formamide reacts faster than 2-oxazolidinones, even though it is a free N–H carbamate derivative. In a similar competitive reaction with a more reactive aldehyde functional group, PhCHO (0.2 mmol) was exclusively hydroborated. However, a competition reaction between 2-oxazolidinones (1c) (0.2 mmol) and the unsaturated alkene (0.2 mmol) or alkyne (0.2 mmol) provides a full hydroboration of the 2-oxazolidinones (1c). Interestingly, the same chemoselectivity towards the carbamate is observed when reacting 2-oxazolidinones (1c) with a pyridine or a nitrile substrate, keeping the latter ones unaffected.
To shed light on the catalytic process, stoichiometric reactions were performed to trap possible intermediates (Fig. 5). The model reaction (Fig. 5A) was catalyzed by complex I and monitored using 1H NMR to gain mechanistic insight into the activation of this carbamate. The activation's first step involved forming complex D with an aldehydic signal [δ = 11.7 ppm], which supports the formation of a formamide during the reaction. Owing to its higher reactivity relative to the carbamate at the reaction temperature, only trace amounts were detected. Therefore, different formamide derivatives were efficiently hydroborated nearly quantitatively in 3 h (Fig. 5B). Deuterium-labeling experiments (Fig. 5C) demonstrated the formation of the N-deuterated methyl with quantitative D-incorporation (>99%), which illustrates that HBpin/DBpin serves as the hydride source. In addition, proton and boron NMR spectroscopy analysis and HRMS showed the formation of the byproduct bis(pinacolboryl)oxide (pinB-O-Bpin). Moreover, studies performed on the corresponding thiocarbamate (Fig. 5D) resulted in the formation of traces of the boronated 1,3-amino-alcohol product, indicating a similar desulfurization.
The proposed active catalyst is formed through the reaction between the Th(IV) metallacycle catalyst (I) and HBpin, which was set as the zero of the free energy, producing the actinide hydride (A′′), at −9.6 kcal mol−1 below that of the catalyst (I), in which the boron atom of the Bpin fragment engages in an interaction with the hydride coordinated to the Th center. The opening of the four-membered metallacycle ring, involving Th–C and B–H bonds, occurs easily via TS-(A′′) at 9.4 kcal mol−1, leading to the formation of the Th–H bond in the intermediate (A′′). The subsequent weakening of the B–H interaction and the rearrangement of the (Me3Si)-N-Si(Me)2CH2-Bpin ligand led to the formation of the active species (A′), lying at only 0.3 kcal mol−1 from the reactants. To reduce computational costs, we performed the mechanistic study of the catalytic cycle using the truncated model (A). In this model, the (Me3Si)-N-Si(Me)2CH2-Bpin ligand is replaced by a (Me3Si)2N (N″) group, making it consistent with the other two ligands of the catalyst (Scheme 1).
![]() | ||
| Scheme 1 DFT-computed energy profile related to the activation pathway of the Th metallacycle catalyst (I). The energy values are ΔG in kcal mol−1 in toluene as the solvent. | ||
The proposed catalytic cycle (Scheme 2) proceeds via the formation of the adduct (B), at −1.5 kcal mol−1 relative to the zero of the free energy, in which carbonyl oxygen of 3-methyl-2-oxazolidinone (1a) interacts with the metal center of the activated catalyst (A) (Scheme 2). From (B), the subsequent insertion of the carbamate C
O portion into the thorium hydride motif, via TS1(C) at 7.0 kcal mol−1, leads to the formation of the intermediate (C) at −27.8 kcal mol−1, overcoming an energy barrier of only 8.5 kcal mol−1.
At this point, intermediate (C) undergoes a reorganization of the metal coordination sphere. Specifically, the thorium center shifts from the carbonyl oxygen of (1a) to the heterocyclic oxygen, yielding the more stable intermediate (D) at −42.4 kcal mol−1. This transformation proceeds via transition state TS2(D) with a calculated energy barrier of only 8.9 kcal mol−1.
Starting from (C) we also investigated an alternative metathesis pathway involving a molecule of HBpin. However, the computed energy barrier was found to be approximately 10 kcal mol−1 higher than that of TS2(D), and, consequently, this competitive route was ruled out.
From intermediate (D) a metathesis reaction occurs with the second molecule of HBpin (Scheme 2). This process involves the Th–O and H–B bonds and leads to the formation of intermediate (E) (at −31.3 kcal mol−1). In this species, the regenerated active catalyst (A) interacts with the formamide product, HC(O)N(CH3)(CH2)2OBpin. The transformation proceeds via transition state TS3(E) at −24.2 kcal mol−1, with a calculated energy barrier of 18.2 kcal mol−1 (Scheme 2). The reaction subsequently proceeds through the insertion of the formamide carbonyl group into the Th–H bond via TS4(F) (−14.0 kcal mol−1), yielding intermediate (F) at −55.1 kcal mol−1. This transformation, calculated relative to the most stable species (D), entails an overall energy barrier of 28.4 kcal mol−1.
These findings are in good agreement with the experimental results obtained from the stoichiometric reaction of 3-methyl-2-oxazolidinone (1a) with catalyst (I) in the presence of two equivalents of HBpin, which yields the corresponding formamide species.
Starting from (D), we also investigated an alternative pathway in which the Bpin moiety of a second HBpin molecule coordinates to the formamide carbonyl oxygen, followed by a concerted hydride transfer to the carbonyl carbon. However, this mechanism entails an energy barrier approximately 13 kcal mol−1 higher than that of TS3(E) (Scheme 2). Consequently, this route was excluded from further considerations.
From (F), subsequent metathesis reaction, involving the Th–O bond and the H–B bond of a third HBpin molecule, affords intermediate (G) at −43.2 kcal mol−1, regenerating the active catalyst (A) that interacts with the reaction product pinBOCH2N(CH3)(CH2)2OBpin. The transition state associated with the formation of (G), TS5(G), lies at −31.2 kcal mol−1, requiring an energy barrier of 23.9 kcal mol−1 (Scheme 2).
From (G), the borylated 2-dimethylaminoethanol (1′a), lying at −90.4 kcal mol−1, is generated through an additional metathesis reaction between the O–Bpin bond of intermediate (G) and the thorium hydride motif of the active catalyst (A) via the TS6(1′a) at −32.4 kcal mol−1. The energy required for the final product formation (1′a), calculated relatively to intermediate (F), amounts to 22.7 kcal mol−1.
Analysis of the complete energy profile for the deoxygenation of (1a) reveals that the conversion of (D) to (F) exhibits the highest overall energy barrier (28.4 kcal mol−1), identifying TS4(F) as the rate-determining state for the entire catalytic cycle.
This result is consistent with the experimental kinetic studies reported for the analogous reaction catalyzed by uranium, showing a first-order dependence of the reaction rate on both the catalyst and HBpin concentrations with an experimental ΔG‡ between 26.9 and 29.7 kcal mol−1 over the temperature range of 70–120 °C.
Based on the above analysis, a possible mechanism for the carbamate activation catalyzed by a thorium complex is presented in Fig. 6. The reactive Th–hydride complex (Th–H) (A) is generated via the cleavage of the Th–CH2 bond in the Th(IV) metallacycle using HBpin.30 Subsequent insertion of the carbamate into the Th–H bond leads to the formation of the Th-alkoxide intermediate (C). At this stage, a rearrangement of the metal coordination environment of (C) occurs, resulting in the cleavage of the carbamate σ(C–O) bond and the formation of the formamide intermediate (D). Subsequent σ-bond metathesis of the Th–O bond in (D), mediated by HBpin, regenerates the thorium hydride (A) to yield the borylated formamide intermediate (HC(O)N(CH3)(CH2)2OBpin), which remains coordinated to the metal center in the transient adduct (E). Insertion of (E) into Th–H bond results in the reduction of the C
O double bond and forms the Th-alkoxide intermediate (F).
Further metathesis of the Th–O bond in (F) with an HBpin produces the double borylated diol amine intermediate BpinOCH2N(CH3)(CH2)2OBpin with the concomitant regeneration of the Th–H species (A). The metathesis of the borylated diol amine with (A) produces the product (1′a) and a Th–O–Bpin species, which reacts with another HBpin releasing the additional product, bis(pinacolato)diboron oxide (pinB–O–Bpin), and regenerates the active catalyst (A), completing the catalytic cycle.
O bonds and cleaving C–O bonds, thereby producing the corresponding borated amino alcohol and trialkyl amine compounds. A broad scope of carbamates was converted into various amines and amino alcohols. Highlighting the potential applicability of carbamates, (−) ephedrine, ephedrine fluorinated analog, and others were obtained from the corresponding carbamate compounds. An(IV) metallacycle and iminato complexes were also found to be active against more complex molecules, demonstrating the potential for late-stage modification of different carbamate drug molecules and leading to interesting biological products. The modification occurs via a selective activation mode toward the carbamate, leaving the rest of the molecules intact, underscoring the potential of actinides/lanthanides as innovative catalysts and paving the way for more efficient and valuable methods for amine synthesis in organic chemistry. Moreover, this protocol is presented for the first time as a polymer-recycling approach for polyurethanes to N-methylamine compounds, in a homogeneous catalytic reaction that is highly sought after in research and industry, as recycling is complicated by the stability of polyurethanes. Kinetic studies displayed a rate law with a first-order dependence on the catalyst and pinacol borane (HBpin), and a zero-order dependence on the carbamate concentration. In addition, different stoichiometric experiments were performed, including deuterated labelling, competition reactions, and a combination with DFT computational methods, allowing us to provide a mechanism for this transformation. Further examination of the chemo- and regio-selectivity of this unusual catalytic reactivity and its application toward introducing new transformations is in progress and will be reported in the future.
Footnote |
| † These authors contributed equally. |
| This journal is © the Partner Organisations 2026 |